Treatment of Acute Decompensated Heart Failure
Initiate immediate treatment with intravenous loop diuretics (furosemide 40-80 mg IV bolus) combined with intravenous vasodilators (nitroglycerin or isosorbide dinitrate) in patients with systolic blood pressure >110 mmHg, while establishing continuous monitoring and supplemental oxygen if SpO2 <90%. 1, 2, 3
Immediate Assessment and Monitoring
Upon presentation, establish continuous monitoring within minutes of patient contact, including: 2, 4
- Pulse oximetry (target SpO2 >90%, or 88-92% in COPD patients) 2, 4
- Blood pressure (measured every 5 minutes until therapy stabilized) 1
- Continuous ECG monitoring 2
- Respiratory rate 2
Obtain immediate diagnostic workup: 3
- 12-lead ECG to exclude ST-elevation MI and identify arrhythmias 3
- Laboratory tests: electrolytes, creatinine, glucose, cardiac troponin, BNP/NT-proBNP 3
- Chest X-ray to evaluate pulmonary congestion and pleural effusion 2
- Echocardiography as soon as possible (unless recently performed) 1
Initial Pharmacological Treatment Algorithm
For Patients with SBP >110 mmHg (Most Common Presentation):
First-line therapy consists of the combination: 1, 2
For Patients with SBP 85-110 mmHg:
- Lower initial diuretic dose 2
- Avoid or use vasodilators with extreme caution 2
- Close monitoring for hypotension 2
For Patients with SBP <85 mmHg (Cardiogenic Shock):
This represents a different clinical entity requiring: 1
- Inotropic agents (dobutamine, dopamine, or milrinone) for documented severe systolic dysfunction with low cardiac output 1, 5, 6
- Invasive hemodynamic monitoring should be considered 1
- Avoid routine diuretics and vasodilators until perfusion restored 1
Respiratory Support Strategy
Administer supplemental oxygen only if SpO2 <90% 2, 4
- For SpO2 90-94%: use clinical judgment based on respiratory work and difficulty 2, 4
- Avoid hyperoxia in non-hypoxemic patients (can cause vasoconstriction and reduce cardiac output) 2
- In COPD patients: target SpO2 88-92% to avoid hypercapnia 2, 4
Non-invasive ventilation (CPAP or BiPAP): 2
- Consider if respiratory rate >25/min or SpO2 <90% despite oxygen 2
- Initiate as soon as possible to reduce intubation rate 2
- CPAP is simpler and preferred in most settings 2
- BiPAP preferred with significant hypercapnia, especially in COPD 2
Intubation indicated if: 2
- PaO2 <60 mmHg, PaCO2 >50 mmHg, pH <7.35 unresponsive to non-invasive measures 2
- Use midazolam (fewer cardiac side effects than propofol) 2
Management of Diuretic Resistance
If inadequate response to initial diuretic therapy: 2, 3
- Switch to continuous IV furosemide infusion after loading dose 3
- Add acetazolamide 500 mg IV once daily if bicarbonate ≥27 mmol/L (especially useful in first 3 days) 2
- Add thiazide diuretic (hydrochlorothiazide) in combination with loop diuretics 2, 3
- Consider ultrafiltration for refractory congestion not responding to medical therapy 1
Management of Pleural Effusion
Consider thoracocentesis if pleural effusion >500 mL (ultrasonographic angle >35 degrees): 2
Critical Pitfalls to Avoid
Do NOT routinely use inotropic agents in normotensive patients without evidence of decreased organ perfusion 1. The ACC/AHA guidelines explicitly state this is a Class III recommendation (harmful) based on increased mortality risk 1.
Do NOT routinely discontinue chronic heart failure medications (ACE inhibitors, beta-blockers, aldosterone antagonists) during acute decompensation unless hemodynamic instability exists 1, 3. Beta-blockers can be safely continued except in cardiogenic shock 1.
Do NOT use invasive hemodynamic monitoring routinely in normotensive patients responding to diuretics and vasodilators 1. Reserve for patients with persistent symptoms despite empiric therapy, uncertain fluid status, worsening renal function, or requirement for parenteral vasoactive agents 1.
Ongoing Monitoring During Treatment
Monitor continuously: 2
- Dyspnea severity (visual analog scale) 2
- Vital signs (BP, HR, respiratory rate, SpO2) 2
- Urine output (strict control) 2
- Daily weight 2
- Peripheral perfusion and congestion signs 2
- Electrolytes and renal function 1, 2, 3
Identification and Treatment of Precipitating Factors
Acute coronary syndromes are a frequent cause requiring: 1, 3
- Urgent cardiac catheterization and angiography with view to revascularization 1
- Particularly important in patients with known/suspected acute myocardial ischemia and inadequate systemic perfusion 1
Other precipitants to address: 1
- Arrhythmias (particularly atrial fibrillation, ventricular tachycardia) 1
- Hypertensive crisis 1
- Valvular complications 1
- Medication/dietary noncompliance 1
- Infections (pneumonia, septicemia) 1
Post-Stabilization Care
Patients require: 1